{
    "2021-09-02": [
        [
            {
                "time": "",
                "original_text": "医药行业21年中报综述：费用调整、研发为重  结构分化、上游占优",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报",
                        "费用调整",
                        "研发",
                        "结构分化",
                        "上游"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122)：中报新冠疫苗业绩超预期 三期临床数据优异",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "中报",
                        "新冠疫苗",
                        "业绩超预期",
                        "三期临床",
                        "数据优异"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年9月投资策略暨中报总结：政策预期基线变化中消化估值",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "中报",
                        "政策预期",
                        "基线变化",
                        "消化估值"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物跌超5%，科创创业ETF(588360)盘中跌超2%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "下跌",
                        "科创创业ETF",
                        "盘中跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "ETF"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2000亿牛股崩了，芯片疫苗股重挫，更有4天跌40%",
                "features": {
                    "keywords": [
                        "牛股",
                        "崩盘",
                        "芯片",
                        "疫苗股",
                        "重挫",
                        "跌幅"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "芯片"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "疫苗股走势疲软，沃森生物跌超6%",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "走势疲软",
                        "沃森生物",
                        "下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股97家创新药企业上半年研发投入逾180亿元",
                "features": {
                    "keywords": [
                        "A股",
                        "创新药",
                        "研发投入",
                        "上半年",
                        "180亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}